Mobile
browsing
RMB11.5million
High-end chemical industry
Heze
Joint capital cooperation
Daozhongdao (Heze) Pharmaceutical Co., Ltd. was established in 2012 with a registered capital of RMB 89.81 million. The company is committed to the R&D, production and sales of anti-tumor drugs, immune preparations, super antibiotics and veterinary drugs.
Construction of biological fermentation, extraction and synthetic production of multi-purpose production lines, products include antifungal drugs: mooring Finn net card, mika fragrance static, Anidulafungin, and other types of immune inhibitors antitumor drugs: sirolimus, tacrolimus, according to the dimension of therapy, for sirolimus, super antibiotic drugs: including the daptomycin, Ramoplanin, and other products. At the same time, production lines for 10 million anti-tumor freeze-dried powder injections will be built.